FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot risk

The Foodstuff and Drug Administration set rigid restrictions on who can acquire Johnson & Johnson’s one particular-dose COVID-19 vaccine on Thursday, indicating the vaccine ought to only be provided to individuals who are not able to acquire a distinctive vaccine or those who precisely request it.

After the one-dose vaccine was authorized in February 2021, the Fda and Facilities for Condition Command and Avoidance briefly paused administering the shot in April after reviews of blood clots in a small range of men and women who been given it. The pause was lifted 11 times later on, with the well being organizations deciding the benefits of the J&J vaccine outweighed the threats.

But the Fda has reversed system, ruling the hazards of the facet influence, called thrombosis with thrombocytopenia syndrome, outweigh the added benefits. The situation, also recognized as vaccine-induced thrombatic thrombocytopenia, is the combination of a blood clot with low platelet count. The blood clots variety in abnormal places, this kind of as veins that drain blood from the mind.

Until late 2021, the U.S. experienced dealt with all a few COVID-19 vaccines out there to Individuals – Pfizer, Moderna, and Johnson & Johnson – as an equivalent alternative, due to the fact substantial scientific tests discovered they all available solid security and early provides had been restricted. But in December of last yr, the CDC formally encouraged the Pfizer and Moderna COVID vaccines around J&J’s.

Thursday’s selection goes one particular step further, formally restricting the vaccine’s use.

‘THIS IS Happening!’: Partner defends COVID vaccines immediately after wife dies from unusual Johnson & Johnson shot complications

Fda vaccine chief Dr. Peter Marks said the company created the choice following re-examining the data on the pitfalls of everyday living-threatening blood clots, concluding that they are minimal to J&J’s vaccine.

“If there is an choice that appears to be equally helpful in protecting against extreme results from COVID-19, we’d alternatively see people today opting for that,” Marks mentioned. “But we have been very careful to say that — as opposed to no vaccine — this is even now a better selection.”

Story continues

The challenge happens in the 1st two months following vaccination, he extra: “So if you had the vaccine 6 months back you can rest soundly tonight recognizing this isn’t an problem.”

Out of the about 17 million People who acquired the J&J shot, federal experts experienced identified 60 instances of the facet impact, which includes nine that ended up fatal, as of mid-March. That quantities to 3.23 blood clot cases for each 1 million J&J shots. The issue is a lot more frequent in women underneath 50, in which the loss of life rate was around 1 for each million shots, according to Marks.

Following the FDA’s final decision, the J&J vaccine will now carry the warning of probable “long-expression and debilitating health and fitness consequences” of the side result.

COVID PANDEMIC: Pfizer-BioNTech requests Fda authorization for fourth COVID vaccine shot for 65 and more mature

A J&J spokesman claimed in an emailed statement: “Data keep on to guidance a favorable benefit-threat profile for the Johnson & Johnson COVID-19 vaccine in adults, when when compared with no vaccine.”

Much more than 200 million Individuals have gained Moderna’s and Pfizer’s two-dose photographs, compared to J&J’s 17 million.

Contributing: Elizabeth Weise and Karen Weintraub, United states Nowadays The Associated Press

This article initially appeared on United states Right now: J & J COVID vaccine use is restricted by Fda owing to blood clot hazard